Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial)
• The first study of its kind on incretin-based therapy together with MDI therapy. • The majority of the studied patient group can be found in primary care settings. • Glycaemic variability will be evaluated by masked continuous glucose monitoring.
| Veröffentlicht in: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.] |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2015
|
| Zugriff auf das übergeordnete Werk: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients |
| Schlagworte: | GLP-1 Liraglutide Insulin injections Diabetes type 2 Overweight |
| Umfang: | 8 |
| Zusammenfassung: | • The first study of its kind on incretin-based therapy together with MDI therapy. • The majority of the studied patient group can be found in primary care settings. • Glycaemic variability will be evaluated by masked continuous glucose monitoring. |
|---|---|
| Beschreibung: | 8 |
| DOI: | 10.1016/j.pcd.2014.07.010 |